Introduction
Typical comorbidities in patients with atopic dermatitis (AD) include allergic asthma, allergic rhinoconjunctivitis, and food allergy [1] . In addition, it has been shown that AD is associated with a number of other diseases, particularly autoimmune disorders such as rheumatoid arthritis, inflammatory bowel disease [2] , systemic lupus erythematosus [3] , vitiligo [4] , and alopecia areata [5] [6] [7] . As early as 1942, atopic individuals were described as being tense, nervous, depressed, introverted and anxious [8] . The goal of the present article is to provide an overview of psychosocial comorbidities currently known to be associated with AD.
Methods
Using the terms atopic dermatitis/eczema, comorbidity, depression, anxiety, attention-deficit/ hyperactivity disorder, anorexia, obsessive compulsive disorder, quality of life, sleep, schizophrenia, we conducted a literature search in PubMed. Articles published over the course of the past 10 years were included in our analysis. We identified 21 stu-dies, including cross-sectional studies, case-control studies, and randomized placebo-controlled trials. The number of patients included in the various studies ranged from 30 to 120,508. The diagnostic definitions we used in our discussion of the various psychosocial disorders are based on current guidelines [1, [9] [10] [11] [12] [13] [14] [15] .
Depression, anxiety disorders and suicidal tendencies (Table 1) The diagnosis of depression is made when two of the following three main symptoms are present: depressed/subdued mood, loss of interest or pleasure, psychomotor retardation, increased fatigue/low energy. Other possible symptoms include the following: decreased ability to concentrate, low self-esteem/confidence, feelings of guilt/worthlessness, negative/pessimistic views of the future, suicidal ideation, self-injury or suicide attempts, sleep disorders and decrease in appetite [9] .
As regards anxiety disorders, a distinction is made between panic disorder, generalized anxiety disorder, social Summary Atopic dermatitis (AD) is a chronic inflammatory disease that may be associated with a number of comorbidities including psychosocial disorders, which are the primary focus of this article. The data presented is based on a literature search in PubMed and subsequent screening of relevant review articles and guidelines.
There is a greater prevalence of depression, anxiety, sleep disorders and suicidal ideation among individuals with AD. The disease negatively impacts patients' quality of life. Children with AD have been shown to more commonly exhibit signs of attention-deficit/hyperactivity disorder. Only little data exists on the association of AD with schizophrenia, eating disorders or obsessive-compulsive disorder.
There is a great need for research in the field of AD-related comorbidities, especially with respect to the question as to whether and how novel treatment options may potentially affect these comorbidities.
phobia, and specific phobias [10] . Both depression and anxiety disorders may lead to suicide [11] .
In the US, a cross-sectional study revealed that patients with AD significantly more frequently showed symptoms of depression such as loss of interest, hopelessness, decrease in appetite, fatigue, and decreased ability to concentrate [16] . This association is most likely bidirectional: on the one hand, AD increases a patient's risk of depression [17] ; on the other hand, stress is a known trigger of AD [18] .
A German cross-sectional study showed an increased risk of suicidal ideation and found symptoms of depression, high disease activity, young age and a weak family bond to be significant predictive factors in this context [19] . According to a Korean cross-sectional study, there is a significantly increased risk of suicidal thoughts, plans to commit suicide, and suicide attempts among adolescents with AD as well [20] .
A Danish cross-sectional study found that patients with moderate-to-severe AD were significantly more often treated with anxiolytic agents and antidepressants than control subjects [21] . Female AD patients have been shown to significantly more frequently develop depression than men [22] . Twins of AD patients are thought to be at increased risk of having anxiety disorders and depression, irrespective of their own atopic status [23] . In their 2018 meta-analysis, Rønnstad et al. demonstrated a significant association of AD with depression and anxiety. However, their analysis was limited in that the various studies had used different definitions of depression and anxiety. Moreover, only few studies had included an assessment of disease severity and of its impact on psychosocial disorders [24] .
Depression seems to be associated with the presence of proinflammatory cytokines, in particular tumor necrosis factor (TNF)-α, interleukin 6 and CRP [25] .
In a randomized, placebo-controlled trial, treatment with the interleukin 4 receptor antagonist dupilumab resulted in improvement in quality of life (DLQI) as well as a decrease in depressive symptoms and anxiety (HADS). Interleukin 4 and interleukin 13 are key cytokines in Th2-mediated inflammation in patients with AD [26] . In summary, the evidence currently available strongly suggests an association of AD with depression, anxiety disorders, and suicidal tendencies. However, more research is needed to corroborate this association and to evaluate the impact disease severity and treatment may potentially have.
Attention-deficit/hyperactivity disorder (ADHD) ( Table 2) ADHD is characterized by the three symptoms inattention, impulsivity, and hyperactivity [12] .
In a case-control study, Tsai et al. showed that children with AD and other atopic diseases (allergic asthma, allergic rhinitis or allergic conjunctivitis) were at a greater risk of developing ADHD. In addition, the risk increased with the number of atopic diseases an individual had; the risk was also greater in individuals living in urban areas [27] . In another case-control study, Schmitt et al. also saw a significant association between ADHD and AD, irrespective of age, gender and other psychiatric disorders. The likelihood of developing ADHD increased with each AD-related doctor's visit [28, 29] . A prospective, non-interventional study has suggested that the risk of developing ADHD increases with the use of antihistamines in early childhood [30] . Moreover, it has been shown that children with AD significantly more often exhibit oppositional defiant behavior and autism spectrum disorders [31] ; the longer AD persists, the greater is the association with mental health problems [32] .
Schizophrenia (Table 3)
Schizophrenia is a syndrome characterized by various mental impairments, including perception, cognition, ego functions, affectivity, lack of energy, and psychomotor activity [13] .
There is only little -and partly controversial -data on the association of schizophrenia and AD. In one study, it was shown that the presence of AD, urticaria, or allergic rhinitis in the absence of asthma significantly increased the risk of schizophrenia [33] . For schizophrenia too, an association with proinflammatory cytokines and Th17 cells has been suggested [34] . Besides, a significant increase in the prevalence of ischemic stroke has been reported in patients with schizophrenia and atopic diseases [35] . In another study, however, seropositivity for specific IgE antibodies was significantly lower in patients with schizophrenia, suggesting a lower prevalence of atopic diseases in schizophrenic individuals [36] .
Obsessive-compulsive disorder (Table 4)
Obsessive-compulsive disorder is characterized by recurrent, stereotypic thoughts and behaviors. There are four subgroups: 1) compulsive checking; 2) compulsive repeating and ordering/arranging; 3) compulsive washing and cleaning; 4) hoarding disorder [37, 38] .
There are hardly any studies on the correlation of AD and obsessive-compulsive disorder. One study examined the association of obsessive-compulsive symptoms in mothers of children with AD. The disease had no impact on the Abbr.: OR, odds ratio.
severity of the mothers' mental disorder and health-related quality [39] .
Anorexia nervosa
Self-induced weight loss in combination with body dysmorphic disorder is the hallmark of anorexia nervosa [14] . For the time period analyzed, no data was found on anorexia nervosa in patients with AD.
Sleep disorders (Table 4)
Cardinal symptoms include difficulties falling and/or staying asleep and daytime drowsiness. As a consequence, patients experience fatigue that may cause impairment of both motor and mental functions as well as psychosocial performance (for example, dealing with stress) [15] . Sleep disturbances are problematic as they severely impair the quality of life of patients with AD [40, 41] .
Several studies have shown sleep disturbances to occur not only in affected patients but also in the parents of children with AD. In particular, shorter sleep duration, difficulties falling asleep, early morning waking, and low sleep efficiency have been reported [40] [41] [42] . Poor sleep quality may result in impaired linear growth of atopic children [43] .
Quality of life (Table 5)
Quality of life is defined as an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns [44] . The Dermatology Life Quality Index (DLQI) is one of the most widely used questionnaires on health-related quality of life (HRQoL), specifically developed for patients with skin diseases [45] . The Dermatitis Family Impact (DFI) questionnaire is a disease-specific tool to assess the impact of AD on the quality of life of the parents and family members of affected children [46] .
Patients with AD have been shown to have a significantly lower quality of life and a higher level of stress than healthy individuals. Quality of life decreases with increasing severity of AD [47] . The presence of a filaggrin mutation has been associated with impaired HRQoL [48] . Adequate treatment of AD has been shown to improve quality of life [49, 50] .
Conclusions
Patients with AD may have a number of psychosocial comorbidities that need to be observed in their clinical care. Based on current data, there is an unequivocal association with depression, anxiety disorders and ADHD. However, the data currently available is by no means conclusive and further research is required to corroborate the association of AD with psychosocial comorbidities. For patients with moderate-to-severe disease in particular, it is recommended to assess the DLQI on a regular basis and, if necessary, to employ specific questionnaires on depression (for example, HADS). Other medical specialties should be involved in the management of these comorbidities as early as possible.
More research is needed, especially with respect to the question as to how novel treatment options for AD may affect not only the cutaneous inflammation but also psychosocial comorbidities.
